If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
7
Followers on Owler
Immunovative
Therapies is specializing in using living immune cells for the treatment of cancer and infectious diseases...
Read more
Overview
Competitors
Funding
News & Insights
Immunovative
Therapies is specializing in using living immune cells for the treatment of cancer and infectious diseases...
Read more
Founder & CEO
Michael Har-Noy
CEO Approval Rating
93/100
Weigh In
2004
Jerusalem
Jerusalem District
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://www.immunovative.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$1M
News
Latest News
Jun 23, 2020
ePRNews
Press Release: Immunovative Therapies : Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Healthy Elderly Adults
Jun 23, 2020
firstwordpharma
Immunovative Therapies: Immunovative Therapies and Mirror Biologics Announce US FDA Clearance of a Universal Anti-Viral Vaccine Phase I/II Clinical Trial for Healthy Elderly Adults
Dec 10, 2018
streetinsider
Press Release: Immunovative Therapies : Immunovative Therapies to Present at Biotech Showcase 2019 in San Francisco
Nov 13, 2018
PharmaLive
Immunovative Therapies: Deep Dive: Immunovative Therapies' Next-Generation Cancer Vaccine Could Change the Game
Jul 13, 2015
PR-INSIDE.COM
Press Release: Immunovative Therapies : Immunovative Therapies, Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Jul 18, 2014
EIN PRESSWIRE
Press Release: Immunovative Therapies : Dr. Michael Har-Noy Will Test AlloVaxTM In Patients With Refractory Head And Neck Cancer
Jul 03, 2014
PR FREE.ORG
Press Release: Immunovative Therapies : Dr. Michael Har-Noy Will Study AlloVaxTM In Patients With Advanced Hepatocellular Carcinoma
Apr 24, 2014
FREE PR NOW
Press Release: Immunovative Therapies : Dr. Michael Har-Noy Describes the Priming Phase of his CRCL-AlloVaxTM Study
Follow and Get Alerts
Immunovative Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 12 + competitors
Trending Companies